Select Page

At APLUSA, we take immense pride in the impact our publications have on enhancing patient care and elevating the overall well-being of individuals. By sharing the results of our tireless work, we provide valuable insights that can truly make a difference. We are thrilled to contribute to the advancement of medical knowledge and to empower healthcare professionals with reliable information that leads to better outcomes. With a steadfast commitment to excellence, we continue to pave the way for a healthier and brighter future for all.

Available Publications based on APLUSA works







 Therapeutic Area


Nicolas Blin, Siegfried Ertl, Elodie Schneider, Christine Maï

Actual usage of current systemic treatments and influence of key drivers for multiple myeloma in the first 2 lines of therapy. Data from real-world study in EU5 countries.





EHA 2023 abstract and poster

HemaSphere 2023;7(S3)

Multiple Myeloma


Silverberg J. I., Mohawk J A., Cirulli J., Nograles K., Punzalan J. C., Kelly K.M., Kim B. S., Guttman-Yassky E., Lebwohl M.

Burden of Disease and Unmet Needs in Atopic Dermatitis: Results From a Patient Survey.


Online article


Dermatitis. Volume: 34 Issue 2: March 16, 2023

Atopic dermatitis

2022 O. Lidove, A. Masseau, D. Lacombe, B. Dussol, S. Bekri, F. Dupuis, Y. Fardini, A. Fouilhoux, E. Noel Attentes et préférences des patients atteints de maladie de Fabry vis-à-vis de leur traitement, sur la base du Patient Needs Questionnaire (PNQ) : résultats intermédiaires de l’étude SATIS-Fab Online article

La Revue de Médecine Interne

Volume 43, Supplement 1, June 2022, Page A75

Rare disease (Fabry)


Guffon, Nathalie; Genevaz, Delphine; Lacombe, Didier; Le Peillet Feuillet, Eliane; Bausson, Pascale; Noel, Esther; Maillot, François; Belmatoug, Nadia; Jaussaud, Roland

Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study


Online article



Orphanet Journal of Rare Diseases (2022) 17:448

Rare disease


K. Aouad, D. Wendling, M. Breban, S. Dadoun, C. Hudry, A. Moltó, E. Pertuiset, L. Gossec

Exploring remission concept in axial spondyloarthritis through the perception of rheumatologists using vignettes and priority ratings


Online article


Rheumatology (Oxford). 2022 May 30;61(6):2603-2608



Frenel, J., Guiu, S., Guéroult-Accolas, L., Zernik, N., Lefeuvre-Plesse, C. and Moley-Massol, I.

Experience of patients with metastatic breast cancer in France: results of the 2021 RÉALITÉS survey and comparison with 2015 results


Online article




Oncologie 2022-1018



Read on

NYbanner image

APLUSA | Who we are

APLUSA is one of the world’s leading independent market research companies dedicated specifically to healthcare.

Serious doctor listening to patient explaining her painful in his office

Patients Charts by APLUSA

Real-World Data (RWD) collected using anonymized patient charts is often augmented with stated reasons that explain individual treatment decisions.


Augmented Insights by APLUSA

APLUSA’s longstanding expertise in market research through global, real-world data collection is enhanced by a growing range of augmented insights solutions.


Interested in discovering results from previous waves of one of our syndicated studies, or getting on board for the next one?
Contact our team via the link below and we'll be delighted to send over more information about our services or to discuss a specific project you are working on

Contact Us